HighTower Advisors’s Bausch Health BHC Stock Holding History

HighTower Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-44,200	Closed	-$40K	–	2302
2018 Q4	$40K	Hold	44,200	–	–	﹤0.01%	2044
2018 Q3	$40K	Buy	+44,200	New	+$1.01M	﹤0.01%	2138
2018 Q2	–	Sell	-40,000	Closed	-$18K	–	2248
2018 Q1	$18K	Sell	40,000 -252,200	-86%	-$4.69M	﹤0.01%	2061
2017 Q4	$339K	Buy	+292,200	New	+$4.63M	﹤0.01%	1641

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.26B AUM 15.11% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

HighTower Advisors's BHC Position: Q2 2022 in Review

HighTower Advisors sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 10,763 shares — an estimated $245K sold.

HighTower Advisors first reported a position in BHC in Q2 2013 and held it in 33 quarters. The position peaked at $6.65M in Q3 2018. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

HighTower Advisors reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
HighTower Advisors sold 10,763 Bausch Health shares in Q2 2022, an estimated $245K.
HighTower Advisors first reported a position in Bausch Health in Q2 2013 and held it in 33 quarters.
HighTower Advisors's Bausch Health position peaked at $6.65M in Q3 2018.
327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on HighTower Advisors's 13F filing for Q2 2022, filed 10 Aug 2022.